StockData
Rezolute, Inc. logo

Rezolute, Inc. (RZLT) stock

RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$4.25+0.24 (+5.85%)

Close on Nov 18, 2026Market cap $411.07MP/E –Yield –

Rezolute operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Rezolute's operating cash flow for the twelve months ending Sep 30, 2026 was -$65.95M. For fiscal 2026 it was -$64.60M. The highest annual figure on record is -$363.22K in fiscal 2011.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$64.60M–
FY2025Jun 30, 2025-$69.08M–
FY2024Jun 30, 2024-$57.37M–
FY2023Jun 30, 2023-$44.48M–
FY2022Jun 30, 2022-$39.62M–
FY2021Jun 30, 2021-$20.44M–
FY2020Jun 30, 2020-$24.17M–
FY2019Jun 30, 2019-$15.30M–
FY2018Jun 30, 2018-$14.11M–
FY2017Jun 30, 2017-$13.31M–
FY2016Jun 30, 2016-$10.49M–
FY2015Jun 30, 2015-$7.08M–
FY2014Jun 30, 2014-$3.17M–
FY2011Dec 31, 2011-$363.22K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026-$18.78M–
Q4 FY2026CQ2 2026Jun 30, 2026-$13.11M–
Q3 FY2026CQ1 2026Mar 31, 2026-$13.74M–
Q2 FY2026CQ4 2025Dec 31, 2025-$20.32M–
Q1 FY2026CQ3 2025Sep 30, 2025-$17.43M–
Q4 FY2025CQ2 2025Jun 30, 2025-$22.00M–
Q3 FY2025CQ1 2025Mar 31, 2025-$17.40M–
Q2 FY2025CQ4 2024Dec 31, 2024-$13.67M–
Q1 FY2025CQ3 2024Sep 30, 2024-$16.01M–
Q4 FY2024CQ2 2024Jun 30, 2024-$18.52M–
Q3 FY2024CQ1 2024Mar 31, 2024-$15.24M–
Q2 FY2024CQ4 2023Dec 31, 2023-$13.02M–
Q1 FY2024CQ3 2023Sep 30, 2023-$10.59M–
Q4 FY2023CQ2 2023Jun 30, 2023-$11.35M–
Q3 FY2023CQ1 2023Mar 31, 2023-$18.05M–
Q2 FY2023CQ4 2022Dec 31, 2022-$7.49M–
Q1 FY2023CQ3 2022Sep 30, 2022-$7.59M–
Q4 FY2022CQ2 2022Jun 30, 2022-$12.11M–
Q3 FY2022CQ1 2022Mar 31, 2022-$13.97M–
Q2 FY2022CQ4 2021Dec 31, 2021-$7.20M–
Q1 FY2022CQ3 2021Sep 30, 2021-$6.34M–
Q4 FY2021CQ2 2021Jun 30, 2021-$5.23M–
Q3 FY2021CQ1 2021Mar 31, 2021-$5.40M–
Q2 FY2021CQ4 2020Dec 31, 2020-$6.26M–
Q1 FY2021CQ3 2020Sep 30, 2020-$3.55M–
Q4 FY2020CQ2 2020Jun 30, 2020-$4.08M–
Q3 FY2020CQ1 2020Mar 31, 2020-$5.68M–
Q2 FY2020CQ4 2019Dec 31, 2019-$5.48M–
Q1 FY2020CQ3 2019Sep 30, 2019-$8.93M–
Q4 FY2018CQ2 2018Jun 30, 2018-$3.88M–
Q3 FY2018CQ1 2018Mar 31, 2018-$2.18M–
Q2 FY2018CQ4 2017Dec 31, 2017-$3.15M–
Q1 FY2018CQ3 2017Sep 30, 2017-$4.91M–
Q4 FY2017CQ2 2017Jun 30, 2017-$3.64M–
Q3 FY2017CQ1 2017Mar 31, 2017-$3.61M–
Q2 FY2017CQ4 2016Dec 31, 2016-$3.09M–
Q1 FY2017CQ3 2016Sep 30, 2016-$2.97M–
Q4 FY2016CQ2 2016Jun 30, 2016-$3.15M–
Q3 FY2016CQ1 2016Mar 31, 2016-$2.54M–

More Rezolute figures

See a number that looks wrong?